Please login to the form below

Not currently logged in
Email:
Password:

Sprout Pharma

This page shows the latest Sprout Pharma news and features for those working in and with pharma, biotech and healthcare.

Valeant swoops on Sprout to claim female sexual disorder drug

Valeant swoops on Sprout to claim female sexual disorder drug

The ink was barely dry on the FDA's approval of Sprout Pharma's controversial 'little pink pill' Addyi before Valeant announced a $1bn deal to buy the company. ... The Sprout deal comes after its $11bn purchase of gastrointestinal drug specialist Salix

Latest news

  • FDA panel backs Sprout Pharma's 'female Viagra' FDA panel backs Sprout Pharma's 'female Viagra'

    FDA panel backs Sprout Pharma's 'female Viagra'. Could be approved for HSDD in pre-menopausal women. ... drug. Sprout acquired rights to the programme in 2011 and says it hopes to market it under the Addyi trade name.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics